1-14 of 14
Authors: Dinesh Kumar
Sort by
Journal Article
0351 Differential Effect of Lemborexant and Zolpidem on Wake Across the Night in Patients with Insomnia Disorder
Thomas Roth and others
Sleep, Volume 46, Issue Supplement_1, May 2023, Pages A155–A156, https://doi.org/10.1093/sleep/zsad077.0351
Published: 29 May 2023
Journal Article
0354 Effect of Lemborexant on Sleep Architecture in Subjects with Comorbid Insomnia and Mild Obstructive Sleep Apnea from a Ph 3 Trial
Clete Kushida and others
Sleep, Volume 46, Issue Supplement_1, May 2023, Page A157, https://doi.org/10.1093/sleep/zsad077.0354
Published: 29 May 2023
Journal Article
0407 Impact of Lemborexant on Daytime Ratings of Sleepiness/Alertness in Subjects with Insomnia Disorder and Baseline Sleepiness
Sonia Ancoli-Israel and others
Sleep, Volume 46, Issue Supplement_1, May 2023, Page A180, https://doi.org/10.1093/sleep/zsad077.0407
Published: 29 May 2023
Journal Article
0451 Effect of Lemborexant Treatment on Polysomnographic Sleep Measures in Older Adults with Insomnia and Objective Short Sleep
Andrew Krystal and others
Sleep, Volume 45, Issue Supplement_1, June 2022, Page A200, https://doi.org/10.1093/sleep/zsac079.448
Published: 25 May 2022
Journal Article
0452 Lemborexant Treatment of Older Adults with Insomnia and Objective Short Sleep: Rates of Response and Remission
Jack Edinger and others
Sleep, Volume 45, Issue Supplement_1, June 2022, Pages A200–A201, https://doi.org/10.1093/sleep/zsac079.449
Published: 25 May 2022
Journal Article
0450 Effect of Lemborexant on Early Morning Awakening in Subjects with Severe Problems with Waking Too Early
Margaret Moline and others
Sleep, Volume 45, Issue Supplement_1, June 2022, Pages A199–A200, https://doi.org/10.1093/sleep/zsac079.447
Published: 25 May 2022
Journal Article
0454 Response to Lemborexant in Older Subjects with Insomnia Disorder and Comorbid Pain at Baseline
Alan Kaplan and others
Sleep, Volume 45, Issue Supplement_1, June 2022, Page A201, https://doi.org/10.1093/sleep/zsac079.451
Published: 25 May 2022
Journal Article
335 Evaluation of Dose Transition From Zolpidem to Lemborexant Across 14 Weeks: Results From a Multicenter Open-label Pilot Study
Russell Rosenberg and others
Sleep, Volume 44, Issue Supplement_2, May 2021, Page A134, https://doi.org/10.1093/sleep/zsab072.334
Published: 03 May 2021
Journal Article
337 A Multicenter Open-label Pilot Study Evaluating Next-Dose Transition From Zolpidem to Lemborexant: Analysis of Female Subgroup
Maha Ahmad and others
Sleep, Volume 44, Issue Supplement_2, May 2021, Pages A134–A135, https://doi.org/10.1093/sleep/zsab072.336
Published: 03 May 2021
Journal Article
336 Effect of Lemborexant Versus Placebo and Zolpidem on REM Sleep by Quarter Night Intervals in Older Adults with Insomnia Disorder
Gary Zammit and others
Sleep, Volume 44, Issue Supplement_2, May 2021, Page A134, https://doi.org/10.1093/sleep/zsab072.335
Published: 03 May 2021
Journal Article
0370 Patient-reported Sleep Onset and Sleep Maintenance: Pooled Analyses of Lemborexant Phase 3 Studies
Get access
Phyllis C Zee and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Pages A150–A151, https://doi.org/10.1093/sleep/zsz067.369
Published: 12 April 2019
Journal Article
0371 Lemborexant Treatment for Insomnia in Phase 3: Impact on Disease Severity
Get access
Tom Roth and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Page A151, https://doi.org/10.1093/sleep/zsz067.370
Published: 12 April 2019
Journal Article
0368 Efficacy and Tolerability of Lemborexant in Female and Male Subjects with Insomnia
Get access
Margaret Moline and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Page A150, https://doi.org/10.1093/sleep/zsz067.367
Published: 12 April 2019
Journal Article
0369 Effect of Lemborexant on Sleep Architecture in Older Adults with Insomnia Disorder
Get access
Margaret Moline and others
Sleep, Volume 42, Issue Supplement_1, April 2019, Page A150, https://doi.org/10.1093/sleep/zsz067.368
Published: 12 April 2019
Advertisement
Advertisement